Virginia Commonwealth University Vibrent Health, VCU Partner to Offer Twin Research Platform Vibrent has developed a digital research platform allowing individual investigators and other twin registries to collaborate on longitudinal studies. Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery Second Genome aims to identify a composite biomarker for the noninvasive diagnosis of nonalcoholic steatohepatitis patients with advanced fibrosis. NIH Awards Research Triangle Institute $5.7M to Help Raise Awareness for All of Us Program The National Institutes of Health also said that it has added four additional healthcare provider organizations to help advance the initiative. Upgrades to CareDx's AlloSure Test Enable Earlier Detection of Transplant Rejection Premium AlloSure 3.0 can diagnose the very early stages of T-cell mediated rejection, allowing clinicians to begin anti-rejection therapies and monitor treatment. Inflammatory Bowel Disease, Prediabetes, Preterm Birth Studies Reveal Microbiome-Host Interactions The studies, which used multi-omic approaches, are part of the integrative Human Microbiome Project (iHMP) — the second phase of the Human Microbiome Project. Aug 19, 2014 VCU Reaps $6.9M for Center Targeting Gene Networks Underlying Alcohol Use Disorders Jul 23, 2014 VCU Team Wins $3M to Search for Biomarkers Caused by Childhood Adversity Jun 26, 2014 VCU Team Marries AFM and qPCR for Highly Multiplexed Biomarker Assays Premium Jan 16, 2014 Genomics in the Journals: 2014.01.16 Oct 30, 2013 VCU Team Searching For Methylation Signature to Predict Chronic Depression Premium Sep 18, 2013 MDx/CDx Focus: Protea, VCU on Molecular Imaging; Cancer Genetics, Roche Servicios Education Program Premium Sep 18, 2013 Protea, VCU Sign Deal to Combine LAESI Technology with Other Molecular Imaging Approaches Sep 9, 2013 NIH Awards $22M for Human Microbiome Project's Second Phase May 25, 2010 EdgeBio, Life Tech to Use SOLiD Methylation Sequencing for Large-Scale VCU Schizophrenia Study Premium May 24, 2010 Life Technologies, EdgeBio Team with VCU on Schizophrenia Markers Apr 14, 2009 Two Teams Devise New Methods for Sequencing-Based Methylation Profiling Premium Breaking News Sequencing-Based MRD Detection in Bone Marrow May Predict ALL Relapse After CAR T-Cell Therapy Metabolomic Study Links 13 Metabolites to Coronary Heart Disease Risk Among African Americans Illumina Wins $8M Jury Verdict in BGI Patent Infringement Suit, Loses Patent Caris Life Sciences Facing FTC Lawsuit After Resisting Subpoena in Illumina, Grail Antitrust Case Biodesix, Spesana Partner to Improve Workflows for Lung Cancer Molecular Diagnostic Tests Eurofins Technologies Obtains CE Marks for SARS-CoV-2, Flu, RSV RT-PCR Kits The Scan Panel Votes for COVID-19 Pill A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says. But Not Harm New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare. Effectiveness Drop Anticipated Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports. Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.